About the event

Held over a weekend, the event is structured around a series of exhibitions, workshops, and panel discussions. The exhibitions showcase a curated selection of photographs that tell compelling stories from various corners of the globe, each image accompanied by detailed narratives that provide context and deeper insight into the historical significance of the scenes depicted. These photographs are drawn from the archives of renowned photographers, as well as emerging talents, ensuring a blend of both classical and contemporary perspectives.

Cliff Palace, Colorado
Ratios Reveal: Breaking Down NovaBridge Biosciences. ADR (NBP)’s Financial Health – DwinneX

Ratios Reveal: Breaking Down NovaBridge Biosciences. ADR (NBP)’s Financial Health

Nora Barnes

Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.

NovaBridge Biosciences. ADR (NASDAQ: NBP) closed the day trading at $3.9 down -2.74% from the previous closing price of $4.01. In other words, the price has decreased by -$2.74 from its previous closing price. On the day, 0.37 million shares were traded. NBP stock price reached its highest trading level at $4.07 during the session, while it also had its lowest trading level at $3.8.

Ratios:

For a better understanding of NBP, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 22.82 and its Current Ratio is at 22.82. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.

Upgrades & Downgrades

In the most recent recommendation for this company, Leerink Partners on October 03, 2025, initiated with a Outperform rating and assigned the stock a target price of $9.

On September 09, 2025, BTIG Research started tracking the stock assigning a Buy rating and target price of $7. On December 09, 2021, Siebert Williams Shank started tracking the stock assigning a Buy rating and target price of $96.Siebert Williams Shank initiated its Buy rating on December 09, 2021, with a $96 target price.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NBP now has a Market Capitalization of 449537632 and an Enterprise Value of 571488896.

Stock Price History:

The Beta on a monthly basis for NBP is 1.66, which has changed by 3.2166142 over the last 52 weeks, in comparison to a change of 0.1177547 over the same period for the S&P500. Over the past 52 weeks, NBP has reached a high of $6.79, while it has fallen to a 52-week low of $0.60. The 50-Day Moving Average of the stock is -12.23%, while the 200-Day Moving Average is calculated to be 50.83%.

Shares Statistics:

Over the past 3-months, NBP traded about 1.45M shares per day on average, while over the past 10 days, NBP traded about 421400 shares per day. A total of 81.79M shares are outstanding, with a floating share count of 67.49M. Insiders hold about 14.78% of the company’s shares, while institutions hold 36.30% stake in the company. Shares short for NBP as of 1763078400 were 4479827 with a Short Ratio of 2.85, compared to 1760486400 on 3654523. Therefore, it implies a Short% of Shares Outstanding of 4479827 and a Short% of Float of 4.8699997.

Earnings Estimates

The dynamic stock of NovaBridge Biosciences. ADR (NBP) is currently being evaluated by a team of 3 analysts, each contributing to its current rating.The consensus estimate for the next quarter is -$0.04, with high estimates of -$0.03 and low estimates of -$0.05.

Analysts are recommending an EPS of between -$0.1 and -$0.61 for the fiscal current year, implying an average EPS of -$0.31. EPS for the following year is -$0.32, with 3.0 analysts recommending between -$0.21 and -$0.49.

DwinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.